1. Pink Sheet
  2. >>Archive

US FDA Communications Post-Gottlieb: No Slow-Down In Statements, But Attribution Changes

 
• By Michael McCaughan

Breakneck pace of press releases under former US FDA Commissioner Scott Gottlieb hasn’t abated in the early days of the Sharpless era – but the attribution has.

Vintage Megaphone
The torrid pace of press releases from the US FDA established under former commissioner Scott Gottlieb has continued under Ned Sharpless.

The Ned Sharpless era at the US Food & Drug Administration is just beginning, but there is already one clear sign of continuity in the transition to a new commissioner at the agency: the pace of press releases hasn’t slowed one bit.

FDA has issued 18 “press announcements” since Sharpless took over as acting commissioner April 8. That is very much in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Pink Sheet

Price Inflation Rebates: Biden Policies Add Teeth To Trump’s Pharma Tariff Threat

 
• By Cathy Kelly

Companies with significant exposure to Medicare and Medicaid have fewer options for passing along higher costs to consumers because of price controls in the programs.

US FDA Acting Drug Center Chief Corrigan-Curay Retiring, Senior Staff Remake Continues

 
• By Derrick Gingery

The news coincides with rumors that Commissioner Martin Makary soon will name a new Center for Drug Evaluation and Research director.

EU Pharma Reform: Lawyers Unpack Diverging Visions For Innovation

 
• By Eliza Slawther

There are now three draft versions of the legislative text that will overhaul the framework governing pharmaceuticals in the EU. Lawyers explain how the approaches proposed by the European Commission, European Parliament and Council of the EU differ and highlight implications for industry.